NG Peer Comparison

BSE: 530897

₹100.50

₹0.45 (0.45%)

As on 23-Oct-2026IST

Market cap

₹34 Cr

Revenue (TTM)

₹17 Cr

P/E Ratio

17.5

P/B Ratio

1

Div. Yield

3.5 %

Edit

	NG	Lotus Eye Hosp	Aspira Pathlab	Samsrita Labs	Soni Medicare
Market cap (₹ Cr)	34	234	130	31	30
Revenue (₹ Cr)	17	57	26	0	24
Net Profit (₹ Cr)	1.93	0.15	-0.45	-8.72	-3.62
Net Margin (%)	10.69	0.26	-1.72	-17,442.00	-15.36
RoE (%)	5.30	0.26	-3.41	-60.02	--
Price to Earnings	17.47	1,563.19	--	--	--
Price-To-Book	0.99	3.86	10.64	2.67	-11.34

Income Statement
Liabilities
Assets
Cashflow
Ratios

Income Statement (₹ Cr)

	NG	Lotus Eye Hosp	Aspira Pathlab	Samsrita Labs	Soni Medicare
Operating Revenue	16.90	57.25	25.90	0.02	23.53
Total Income	18.03	58.45	26.43	0.05	23.53
Total Expenditure	15.02	52.40	24.92	8.77	25.19
EBITDA	1.88	4.85	0.99	-8.75	-1.66
Depreciation	0.57	4.57	1.58	0.00	0.52
EBIT	1.31	0.28	-0.59	-8.75	-2.18
Interest	0.06	1.25	0.39	0.00	1.36
Other Income	1.13	1.20	0.53	0.03	0.00
Exceptional Items	0.00	-0.01	0.00	0.00	0.00
Profit before Tax	2.38	0.23	-0.45	-8.72	-3.54
Provision for Tax	0.45	0.08	0.00	0.00	0.08
Profit after Tax	1.93	0.15	-0.45	-8.72	-3.62

Liabilities (₹ Cr)

	NG	Lotus Eye Hosp	Aspira Pathlab	Samsrita Labs	Soni Medicare
Shareholder's Funds	33.56	60.14	12.23	11.75	-1.23
Minority Interest	0.00	0.00	0.00	0.00	0.00
Non-Current Liabilities	0.00	13.12	3.08	0.09	12.27
Current Liabilities	1.90	9.34	3.20	2.54	15.64
Total Liabilities	41.62	69.57	17.46	15.57	22.17

Assets (₹ Cr)

	NG	Lotus Eye Hosp	Aspira Pathlab	Samsrita Labs	Soni Medicare
Non-Current Assets	32.40	59.70	8.97	11.84	6.70
Current Assets	2.94	11.37	4.59	2.54	17.61
Total Assets	41.62	69.57	17.46	15.57	22.17
Total Debt*	1.78	0.61	1.21	2.43	10.52
Net Current Assets	1.04	2.03	1.39	0.01	1.97
Contingent Liabilities	0.09	0.82	1.12	--	0.03

Cashflow (₹ Cr)

	NG	Lotus Eye Hosp	Aspira Pathlab	Samsrita Labs	Soni Medicare
Cash From Operating Activities	1.81	2.70	1.83	-0.23	1.47
Cash Flow from Investing Activities	-1.23	-3.99	0.12	--	-0.52
Cash from Financing Activities	-0.62	-1.60	-0.99	0.22	-0.24
Net Cash Inflow / Outflow	-0.03	-2.89	0.95	0.00	0.71

Ratios

Profitability Ratios

	NG	Lotus Eye Hosp	Aspira Pathlab	Samsrita Labs	Soni Medicare
ROCE (%)	23.83	3.10	19.27	-1.79	6.58
ROE (%)	5.30	0.26	-3.41	-60.02	-12.79
ROA (%)	5.00	0.20	-2.52	-121.26	-14.80
EBIT Margin (%)	7.75	0.50	-2.29	-48,627.78	-9.26
Net Margin (%)	10.69	0.26	-1.72	-17,442.00	-15.36
Cash Profit Margin (%)	0.00	0.00	0.00	-4.85	0.00

Growth Ratios

	NG	Lotus Eye Hosp	Aspira Pathlab	Samsrita Labs	Soni Medicare
Revenue Growth (%)	2.15	14.08	14.56	--	-25.05
EBIT Growth (%)	16.96	-40.59	-123.61	-4.35	-255.13
Net Profit Growth (%)	-74.09	-77.38	-117.74	-3.83	-1,029.31
EPS Growth (%)	-74.09	-76.43	-117.74	-8.58	-1,029.31
Book Value Growth (%)	6.59	1.00	19.94	-2.32	-19.64

Valuation Ratios

	NG	Lotus Eye Hosp	Aspira Pathlab	Samsrita Labs	Soni Medicare
Price / Earnings	17.47	1,514.26	-285.78	-3.74	0.00
Price / Book Value	0.99	3.86	10.64	2.67	15.72
Dividend Yield (%)	3.48	0.00	0.00	0.00	0.00
EV/EBITDA	17.49	50.06	130.37	-3.49	22.85
Market Cap (₹ Cr)	54.63	145.37	87.73	--	20.42

Solvency Ratios

	NG	Lotus Eye Hosp	Aspira Pathlab	Samsrita Labs	Soni Medicare
Debt to Equity	0.00	0.17	0.11	0.00	-9.00
Short term debt to equity ratio	0.05	--	--	0.20	0.31
Current Ratio	1.55	1.22	1.43	1.00	1.13
Quick Ratio	1.12	0.81	1.22	1.00	1.07
Interest Coverage	39.34	1.18	-0.17	-182.25	-1.61

Operating Efficiency Ratios

	NG	Lotus Eye Hosp	Aspira Pathlab	Samsrita Labs	Soni Medicare
Debtors to sales (%)	2.84	2.11	6.69	111.11	54.17
Asset Turnover	0.44	0.75	1.44	0.00	0.96
Receivable days	6.31	9.50	38.11	--	96.98
Inventory Days	15.24	25.93	7.95	--	8.69
Payable days	0.00	80.52	72.32	--	251.51
Cash Conversion Cycle	21.54	-45.09	-26.26	--	-145.84

*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.

Annual
Quarterly